Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henk J van Leeuwen

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
The Annals of Pharmacotherapy|February 18, 2011
High unbound fraction of valproic acid in a hypoalbuminemic critically ill patient on renal replacement therapyMonique M R de Maat, Henk J van Leeuwen, Peter M Edelbroek
Critical Care (London, England)|July 8, 2021
The chicken or the egg: low testosterone predisposes for COVID-19 or COVID-19 induces a decrease in testosterone?Roeland F Stolk, Henk J van Leeuwen, Matthijs Kox, et al.
Nederlands Tijdschrift Voor Geneeskunde|February 26, 2015
[Ceftriaxone-induced immune haemolytic anaemia and multi-organ failure]Chantal E Mulkens, Ellen G van Lochem, Claudia C Folman, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|December 23, 2021
What extreme laboratory values can be obtained that (some) patients can survive with?Pim M W Janssens, Michiel W Pot, Moniek Wouters, et al.
Shock (Augusta, Ga.)|December 23, 2004
Plasma vascular endothelial growth factor in severe sepsisMichiel van der Flier, Henk J van Leeuwen, Kok P van Kessel, et al.
BMC Pharmacology & Toxicology|February 6, 2024
Large variation in anti-factor Xa levels with nadroparin as thromboprophylaxis in COVID-19 and non-COVID-19 critically ill patientsMonique M R de Maat, Henk J van Leeuwen, Lian Roovers, et al.
Critical Care Medicine|May 29, 2003
Lipoprotein metabolism in patients with severe sepsisHenk J van Leeuwen, Eric C J M Heezius, Geesje M Dallinga, et al.
Antimicrobial Agents and Chemotherapy|May 13, 2015
Altered Micafungin Pharmacokinetics in Intensive Care Unit PatientsVincent J Lempers, Jeroen A Schouten, Nicole G Hunfeld, et al.
Intensive Care Medicine|June 19, 2007
A Bayesian decision-support system for diagnosing ventilator-associated pneumoniaCarolina A M Schurink, Stefan Visscher, Peter J F Lucas, et al.
Clinical Pharmacokinetics|February 2, 2017
Population Pharmacokinetic Model and Pharmacokinetic Target Attainment of Micafungin in Intensive Care Unit PatientsLisa C Martial, Rob Ter Heine, Jeroen A Schouten, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
The Annals of Pharmacotherapy|February 18, 2011
High unbound fraction of valproic acid in a hypoalbuminemic critically ill patient on renal replacement therapyMonique M R de Maat, Henk J van Leeuwen, Peter M Edelbroek
Critical Care (London, England)|July 8, 2021
The chicken or the egg: low testosterone predisposes for COVID-19 or COVID-19 induces a decrease in testosterone?Roeland F Stolk, Henk J van Leeuwen, Matthijs Kox, et al.
Nederlands Tijdschrift Voor Geneeskunde|February 26, 2015
[Ceftriaxone-induced immune haemolytic anaemia and multi-organ failure]Chantal E Mulkens, Ellen G van Lochem, Claudia C Folman, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|December 23, 2021
What extreme laboratory values can be obtained that (some) patients can survive with?Pim M W Janssens, Michiel W Pot, Moniek Wouters, et al.
Shock (Augusta, Ga.)|December 23, 2004
Plasma vascular endothelial growth factor in severe sepsisMichiel van der Flier, Henk J van Leeuwen, Kok P van Kessel, et al.
BMC Pharmacology & Toxicology|February 6, 2024
Large variation in anti-factor Xa levels with nadroparin as thromboprophylaxis in COVID-19 and non-COVID-19 critically ill patientsMonique M R de Maat, Henk J van Leeuwen, Lian Roovers, et al.
Critical Care Medicine|May 29, 2003
Lipoprotein metabolism in patients with severe sepsisHenk J van Leeuwen, Eric C J M Heezius, Geesje M Dallinga, et al.
Antimicrobial Agents and Chemotherapy|May 13, 2015
Altered Micafungin Pharmacokinetics in Intensive Care Unit PatientsVincent J Lempers, Jeroen A Schouten, Nicole G Hunfeld, et al.
Intensive Care Medicine|June 19, 2007
A Bayesian decision-support system for diagnosing ventilator-associated pneumoniaCarolina A M Schurink, Stefan Visscher, Peter J F Lucas, et al.
Clinical Pharmacokinetics|February 2, 2017
Population Pharmacokinetic Model and Pharmacokinetic Target Attainment of Micafungin in Intensive Care Unit PatientsLisa C Martial, Rob Ter Heine, Jeroen A Schouten, et al.
Pageof 2